Paul Staats

During the COVID-19 pandemic, digital tools enabled pathologists to work safely at a distance — an emergency measure that quickly became a reliable part of everyday clinical care1,2. Temporary regulatory flexibility enabled remote participation in diagnostic workflows, including cytology review, in which individual patient cells are examined under a microscope to identify abnormalities or suspicious features. A common example is the Pap smear tests for cervical screening.